The purpose of this study is to evaluate the abuse potential and safety of samidorphan in healthy, non-dependent, adult, recreational opioid users.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
59
Alkermes Investigational Site
Overland Park, Kansas, United States
Pharmacodynamics: Abuse potential measured by visual analog scales (VAS)
Time frame: Approximately 4 weeks
Safety: Incidence of adverse events (AEs)
Time frame: Approximately 5.5 weeks
Pharmacokinetics: Plasma concentrations of samidorphan and metabolite
Time frame: Approximately 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.